Higher dextrose delivery via TPN related to the development of hyperglycemia in non-diabetic critically ill patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The beneficial effects of total parenteral nutrition (TPN) in improving the nutritional status of malnourished patients during hospital stays have been well established. However, recent randomized trials and meta-analyses have reported an increased rate of TPN-associated complications and mortality in critically ill patients. The increased risk of complications during TPN therapy has been linked to the development of hyperglycemia,especially during the first few days of TPN therapy. This retrospective study was conducted to determine whether the amount of dextrose from TPN in the 1st week in the intensive care unit (ICU) was related to the development of hyperglycemia and the clinical outcome. We included 88 non-diabetic critically ill patients who stayed in the medical ICU for more than two days. The subjects were 65 ± 16 years old, and the mean APACHE (Acute Physiology and Chronic Health Evaluation) Ⅱ score upon admission was 20.9 ± 7.1. The subjects received 2.3 ± 1.4 g/kg/day of dextrose intravenously. We divided the subjects into two groups according to the mean blood glucose (BG) level during the 1st week of ICU stay: < 140 mg/dl vs ≥ 140 mg/dl. Baseline BG and the amount of dextrose delivered via TPN were significantly higher in the hyperglycemia group than those in the normoglycemia group. Mortality was higher in the hyperglycemia group than in the normoglycemia group (42.4% vs 12.8%,P = 0.008). The amount of dextrose from TPN was the only significant variable in the multiple linear regression analysis, which included age, APACHE Ⅱ score, baseline blood glucose concentration and dextrose delivery via TPN as independent variables. We concluded that the amount of dextrose delivered via TPN might be associated with the development of hyperglycemia in critically ill patients without a history of diabetes mellitus. The amount of dextrose in TPN should be decided and adapted carefully to maintain blood glucose within the target range.
Abstract
The beneficial effects of total parenteral nutrition (TPN) in improving the nutritional status of malnourished patients during hospital stays have been well established. However, recent randomized trials and meta-analyses have reported an increased rate of TPN-associated complications and mortality in critically ill patients. The increased risk of complications during TPN therapy has been linked to the development of hyperglycemia,especially during the first few days of TPN therapy. This retrospective study was conducted to determine whether the amount of dextrose from TPN in the 1st week in the intensive care unit (ICU) was related to the development of hyperglycemia and the clinical outcome. We included 88 non-diabetic critically ill patients who stayed in the medical ICU for more than two days. The subjects were 65 ± 16 years old, and the mean APACHE (Acute Physiology and Chronic Health Evaluation) Ⅱ score upon admission was 20.9 ± 7.1. The subjects received 2.3 ± 1.4 g/kg/day of dextrose intravenously. We divided the subjects into two groups according to the mean blood glucose (BG) level during the 1st week of ICU stay: < 140 mg/dl vs ≥ 140 mg/dl. Baseline BG and the amount of dextrose delivered via TPN were significantly higher in the hyperglycemia group than those in the normoglycemia group. Mortality was higher in the hyperglycemia group than in the normoglycemia group (42.4% vs 12.8%,P = 0.008). The amount of dextrose from TPN was the only significant variable in the multiple linear regression analysis, which included age, APACHE Ⅱ score, baseline blood glucose concentration and dextrose delivery via TPN as independent variables. We concluded that the amount of dextrose delivered via TPN might be associated with the development of hyperglycemia in critically ill patients without a history of diabetes mellitus. The amount of dextrose in TPN should be decided and adapted carefully to maintain blood glucose within the target range.
참고문헌 (22)
- Heyland DK, "Total parenteral nutrition in the surgical patient: a meta-analysis", Can J Surg, 44, pp.102~111 (2001)
- der Voort PH, "Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients", Clin Endocrinol (Oxf), 64, pp.141~145 (2006)
- McClave SA, "A.S.P.E.N. Board of Directors; American College of Critical Care Medicine; Society of Critical Care Medicine. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)", J Parenter Enteral Nutr, 33, pp.277~316 (2009)
- Singer P, "ESPEN Guidelines on Parenteral Nutrition: intensive care", Clin Nutr, 28, pp.387~400 (2009)
- Cheung NW, "Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition", Diabetes Care, 28, pp.2367~2371 (2005)
- Heuer JG, "Effects of hyperglycemia and insulin therapy on outcome in a hyperglycemic septic model of critical illness", J Trauma, 60, pp.865~872 (2006)
- Rosmarin DK, "Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose", Nutr Clin Pract, 11, pp.151~156 (1996)
- Lin LY, "Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition", Am J Med Sci, 333, pp.261~265 (2007)
- Pasquel FJ, "Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients", Diabetes Care, 33, pp.739~741 (2010)
- van den Berghe G, "Intensive insulin therapy in the critically ill patients", N Engl J Med, 345, pp.1359~1367 (2001)
- Van den Berghe G, "Intensive insulin therapy in the medical ICU", N Engl J Med, 354, pp.449~461 (2006)
- Van den Berghe G, "Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target", J Clin Endocrinol Metab, 94, pp.3163~3170 (2009)
- Sacks G, "Parenteral nutrition implementation and management. In: Merrit R, editor. The A.S.P.E.N. Nutrition Support Practice Manual. 2nd ed", pp.108~117 (2005), Sliver Spring: American Society for Parenteral and Enteral Nutrition
- McMahon M, "Parenteral nutrition in patients with diabetes mellitus: theoretical and practical considerations", JPEN J Parenter Enteral Nutr, 13, pp.545~553 (1989)
- Trujillo EB, "Metabolic and monetary costs of avoidable parenteral nutrition use", JPEN J Parenter Enteral Nutr, 23, pp.109~113 (1999)
- Saalwachter AR, "A nutrition support team led by general surgeons decreases inappropriate use of total parenteral nutrition on a surgical service", Am Surg, 70, pp.1107~1111 (2004)
- Dissanaike S, "The risk for bloodstream infections is associated with increased parenteral caloric intake in patients receiving parenteral nutrition", Crit Care, 11, pp.114~ (2007)
- Sheean PM, "Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation", Biol Blood Marrow Transplant, 12, pp.656~664 (2006)
- Vincent JL, "Clinical review: scoring systems in the critically ill", Crit Care, 14, pp.207~ (2010)
- 신유미, "Comparison of time course changes in blood glucose, insulin and lipids between high carbohydrate and high fat meals in healthy young women", Nutrition Research and Practice, 3(2), pp.128~133 (2009), 한국영양학회
- Yokoyama J, "Effects of highmonounsaturated fatty acid enteral formula versus high-carbohydrate enteral formula on plasma glucose concentration and insulin secretion in healthy individuals and diabetic patients", J Int Med Res, 36, pp.137~146 (2008)
- Pohl M, "Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial", Eur J Clin Nutr, 59, pp.1221~1232 (2005)